BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32762692)

  • 1. Contribution of CYP24A1 variants in coronary heart disease among the Chinese population.
    Qian P; Cao X; Xu X; Duan M; Zhang Q; Huang G
    Lipids Health Dis; 2020 Aug; 19(1):181. PubMed ID: 32762692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP24A1 rs1570669 Variant Has a Protective Effect against Tumors of the Urinary System.
    Sun Y; Wang X; Wu J; Xiong Z; Li H; Liu Y; Liu J; Ding Y; Jin T
    Public Health Genomics; 2020; 23(5-6):200-209. PubMed ID: 33113544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of
    Wang F; Luo D; Chen J; Pan C; Wang Z; Fu H; Xu J; Yang M; Mo S; Zhuang L; Wang W
    J Genet; 2022; 101():. PubMed ID: 36226342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association analysis between CYP24A1 genetic polymorphisms and the risk of ischemic stroke in Chinese Han population.
    Yang W; Ma F; Wang L; He X; Zhang H; Zheng J; Wang Y; Jin T; Yuan D; He Y
    Brain Behav; 2020 Feb; 10(2):e01503. PubMed ID: 31872978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between CYP24A1 Polymorphisms and Bladder Cancer Risk in the Chinese Han Population.
    Zhang T; Hu B; Xu S; Wang Y; Zhang H; Li X; Li X; Jin T; He Y
    Biochem Genet; 2024 Apr; ():. PubMed ID: 38642176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of lncRNA CASC8, CASC11, and PVT1 Genetic Variants to the Susceptibility of Coronary Heart Disease.
    Lu Y; Yuan W; Wang L; Ning M; Han Y; Gu W; Zhao T; Shang F; Guo X
    J Cardiovasc Pharmacol; 2021 Jun; 77(6):756-766. PubMed ID: 34001726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CYP17A1 Polymorphisms Are Linked to the Risk of Coronary Heart Disease in a Case-Control Study.
    Lu S; Zhong J; Zhang Y; Huang K; Wu M; Zhou Y; Li Q; Chen Z; Zhang S; Zhou H
    J Cardiovasc Pharmacol; 2019 Aug; 74(2):98-104. PubMed ID: 31356544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association study between CYP24A1 gene polymorphisms and risk of liver, lung and gastric cancer in a Chinese population.
    Xiong Q; Jiao Y; Yang P; Liao Y; Gu X; Hu F; Chen B
    Pathol Res Pract; 2020 Dec; 216(12):153237. PubMed ID: 33065483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between PPAP2B gene polymorphisms and coronary heart disease susceptibility in Chinese Han males and females.
    Sun YX; Gao CY; Lu Y; Fu X; Jia JG; Zhao YJ; Li LD; Dui HZ; Zhang XY; Li ZY; Lei L; Zhang WF; Yuan YQ
    Oncotarget; 2017 Feb; 8(8):13166-13173. PubMed ID: 28061459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variants in CYP11B1 influence the susceptibility to coronary heart disease.
    Huang X; Cheng Y; Wang N
    BMC Med Genomics; 2022 Jul; 15(1):158. PubMed ID: 35831903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Polymorphisms of FAM13A, PHLDB1, and CYP24A1 in Breast Cancer Risk.
    Wei Y; Wang X; Zhang Z; Xie M; Li Y; Cao H; Zhao X
    Curr Mol Med; 2019; 19(8):579-588. PubMed ID: 31215377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The associations between CYP24A1 polymorphisms and cancer susceptibility: A meta-analysis and trial sequential analysis.
    Zhu M; Qiu S; Zhang X; Wang Y; Souraka TDM; Wen X; Liang C; Tu J
    Pathol Res Pract; 2018 Jan; 214(1):53-63. PubMed ID: 29254801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphism in CYP24A1 Is Associated with Lung Cancer Risk: A Case-Control Study in Chinese Female Nonsmokers.
    Qu R; Li X; Quan X; Xia L; Fang X; Li H; Zhou B
    DNA Cell Biol; 2019 Mar; 38(3):243-249. PubMed ID: 30724597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NT5C2 Gene Polymorphisms and the Risk of Coronary Heart Disease.
    Chen X; Zhang Z; Wang X; Chen Y; Wang C
    Public Health Genomics; 2020; 23(3-4):90-99. PubMed ID: 32541135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions among genetic variants from SREBP2 activating-related pathway on risk of coronary heart disease in Chinese Han population.
    Liu X; Li Y; Lu X; Wang L; Zhao Q; Yang W; Huang J; Cao J; Li H; Gu D
    Atherosclerosis; 2010 Feb; 208(2):421-6. PubMed ID: 19740467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of IL-7/7R genetic polymorphisms in coronary heart disease in Chinese Han population.
    Sun Y; Yan J; Zhang J; Wang A; Zou J; Gao C
    Int Immunopharmacol; 2020 Feb; 79():106084. PubMed ID: 31865243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDKN2BAS polymorphisms are associated with coronary heart disease risk a Han Chinese population.
    Zhao Q; Liao S; Wei H; Liu D; Li J; Zhang X; Yan M; Jin T
    Oncotarget; 2016 Dec; 7(50):82046-82054. PubMed ID: 27741513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variants in the SMARCA4 gene was associated with coronary heart disease susceptibility in Chinese han population.
    Guo X; Wang X; Wang Y; Zhang C; Quan X; Zhang Y; Jia S; Ma W; Fan Y; Wang C
    Oncotarget; 2017 Jan; 8(5):7350-7356. PubMed ID: 28055962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of platelet-activating factor receptor gene rs5938 (G/T) and rs313152 (T/C) polymorphisms with coronary heart disease and blood stasis syndrome in a Chinese Han population.
    Zheng GH; Xiong SQ; Chen HY; Mei LJ; Wang T
    Chin J Integr Med; 2017 Dec; 23(12):893-900. PubMed ID: 28197937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction effects between Paraoxonase 1 variants and cigarette smoking on risk of coronary heart disease in a Singaporean Chinese population.
    Han Y; Dorajoo R; Ke T; Ayala B; Chang X; Khor CC; van Dam RM; Yuan JM; Koh WP; Liu J; Goh DY; Friedlander Y; Heng CK
    Atherosclerosis; 2015 May; 240(1):40-5. PubMed ID: 25746376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.